FidoCure®

FidoCure® is at the forefront of precision medicine in canine oncology, grounded in the understanding that cancer is fundamentally a genetic disease. Building upon decades of research in both human and veterinary oncology, FidoCure® adapts the successful precision medicine and targeted therapy approaches used in human cancer treatment to the veterinary field. The company enables veterinarians to utilize genetic sequencing and targeted therapies, providing advanced treatment options for dogs diagnosed with cancer.

FidoCure® is dedicated to expanding the diagnostic and therapeutic resources available to veterinary oncologists. With a network of over 143 clinics and 180 veterinary oncologists across the US, FidoCure® collaborates with veterinary partners who possess extensive experience in treating canine cancer. Together, FidoCure® and its partners are committed to fighting canine cancer through innovative and personalized treatment strategies.